Kaplan-Meier curves show survival probabilities over 60 months for refractory NSCLC patients, comparing outcomes with and without chemotherapy, both overlap-weighted and unweighted. The number at risk is noted for each arm.
Sequential radiotherapy and immunotherapy (#iRT) provided longer overall survival than concurrent iRT for newly diagnosed advanced non–small cell lung cancer, with additional benefit from chemotherapy.
ja.ma/3PuvMYw